The global Virology Specimen Collection Market boasts a total value of $5.6 billion in 2021 and is projected to register a growth rate of -0.6% to reach a value of $5.4 billion by 2026. Growth in this market is mainly driven by the rising prevalence of viral diseases, the increasing prevalence of human papillomavirus (HPV) and cervical cancer, and the growing number of blood donations.

Virology Specimen Collection Market Key Players

-          Becton, Dickson and Company (US)

-          Quidel Corporation (US)

-          Thermo Fisher Scientific Inc. (US)

-          Trinity Biotech (Ireland)

-          Titan Biotech Ltd. (India)

Download a FREE Sample PDF of the Global Virology Specimen Collection Market Research Report at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150226807&utm_source=Ganesh&utm_medium=P

The market is highly consolidated. The top players— Becton, Dickinson and Company (US), Quidel Corporation (US), Thermo Fisher Scientific Inc. (US), Trinity Biotech (Ireland), Titan Biotech Ltd. (India)-in the market accounted for a combined majority market share in 2020. There is a high degree of competition among the market players. Only major companies can afford high-capital investments as well as the high cost of R&D and manufacturing. This will prevent new entrants from entering this market.

This report categorizes the virology specimen collection market into the following segments and subsegments:

By Product Type

• Blood Collection Kits
• Specimen Collection Tubes
• Viral Transport Media
• Swabs

By Sample

• Blood Samples
• Nasopharyngeal Samples
• Throat Samples
• Nasal Sampls
• Cervical Samples
• Oral Samples
• Other Samples

By Region

• North America
• Europe
• Asia Pacific
• Rest of the World

In 2020, virology transport media segment accounted for the largest share of the virology specimen collection market, by product type

The market is segmented into viral transport media, swabs, blood collection kits, and specimen collection tubes. The viral transport media accounted for the largest share of the market in 2020, mainly due to the rising number of blood donations, and the emergence of new pathogens.

In 2020, nasopharyngeal sample segment accounted for the largest share in the market, by technology

The virology specimen collection market is segmented blood, cervical, nasal, nasopharyngeal, throat, oral, and other (conjunctiva, feces, nasopharyngeal aspirate or wash, urethral, urine samples, semen, sputum, and cerebrospinal fluid) samples. In 2020, nasopharyngeal samples accounted for the largest share of the market. The large share of this segment can be attributed primarily due to the fast detection of transfusion transmissible infection (TTIs), and the increasing prevalence of HPV-related cancers (all cervical cancers) & human papillomavirus (HPV).

Direct Purchase of the Global Virology Specimen Collection Market Research Report at https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=150226807&utm_source=Ganesh&utm_medium=P

North America is the largest regional market for virology specimen collection

The global virology specimen collection market has been segmented into five major regions—North America, Europe, the Asia Pacific, and the Rest of the World. North America accounted for the largest regional market for virology specimen collection. The large share of North America in this market can be attributed to the increasing adoption of NAT (due to the high prevalence of TTIs), and the technological developments including portable diagnostics.